Open access
146
Views
2
CrossRef citations to date
0
Altmetric
Review
MYC as therapeutic target in leukemia and lymphoma
Maria G Cortiguera1 Institute of Biomedicine and Biotechnology of Cantabria (IBBTEC), CSIC-University of Cantabria
, Ana Batlle-López1 Institute of Biomedicine and Biotechnology of Cantabria (IBBTEC), CSIC-University of Cantabria;2 Department of Hemathology, Hospital Universitario Marqués de Valdecilla
, Marta Albajar1 Institute of Biomedicine and Biotechnology of Cantabria (IBBTEC), CSIC-University of Cantabria;2 Department of Hemathology, Hospital Universitario Marqués de Valdecilla
, M Dolores Delgado1 Institute of Biomedicine and Biotechnology of Cantabria (IBBTEC), CSIC-University of Cantabria;3 Department of Molecular Biology, University of Cantabria, Santander, Spain
& Javier León1 Institute of Biomedicine and Biotechnology of Cantabria (IBBTEC), CSIC-University of Cantabria;2 Department of Hemathology, Hospital Universitario Marqués de ValdecillaCorrespondence[email protected]
Pages 75-91
|
Published online: 22 Jul 2015
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.